Promontory Therapeutics Revenue

Biotechnology Research • Manhattan, New York, United States • 11-20 Employees

Promontory Therapeutics revenue & valuation

Annual revenue	$1,283,325
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$4,200,000
Total funding	No funding

Key Contacts at Promontory Therapeutics

Matthew Price

Co-Founder & Coo, Director

Marie-Therese Hehenberger

Director, Cmc & Supply Chain

Joseph Odonnell

Senior Medical Director

Christina Yim

Senior Director Of Research And Development

Elodie Benard

Associate Director Of Clinical Operations

Aamena Chaudhry

Senior Director, Drug Safety

Company overview

Headquarters	1350 Avenue of the Americas, 23rd Fl, New York, NEW YORK 10019, US
Phone number	+16463802441
Websites	promontorytx.com phosplatin.com
NAICS	541714
SIC	283
Keywords	Biotechnology, Pharmaceuticals, Oncology, Therapeutics
Founded	2010
Employees	11-20
Socials

Promontory Therapeutics Email Formats

Promontory Therapeutics uses 4 email formats. The most common is {first initial}{last name} (e.g., jdoe@phosplatin.com), used 62.5% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@phosplatin.com	81.3%
{first name}{last name}	johndoe@promontorytx.com	12.5%
{last name}	doe@promontorytx.com	6.2%

About Promontory Therapeutics

Promontory Therapeutics is a private, clinical stage biopharmaceutical company founded in 2010, and funded by private investors and family investment offices in the U.S., Europe and Asia. It holds the exclusive, global license to phosphaplatins, a family of novel agents currently in clinical development for the treatment of both solid tumors and hematological cancers. Phosphaplatins are the result of over 20 years of work by the inventor, and uniquely combine an immunological form of apoptosis with an attractive safety profile. The lead agent is the subject of two approved IND applications with the US FDA, and of a collaboration and option agreement for rights in Greater China with SciClone Pharmaceuticals. Website: www.phosplatin.com

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Director

C-Suite

Vice President

Employees by Department

Promontory Therapeutics has 9 employees across 6 departments.

Departments

Number of employees

Funding Data

Promontory Therapeutics has never raised funding before.

Promontory Therapeutics Tech Stack

Discover the technologies and tools that power Promontory Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Google Workspace

Adobe Fonts

Font scripts

Modernizr

JavaScript libraries

Lodash

JavaScript libraries

Emotion

Development

Squarespace Commerce

Ecommerce

reCAPTCHA

Security

GoDaddy

Hosting

Stimulus

JavaScript frameworks

HSTS

Security

Open Graph

Miscellaneous

Vimeo

Video players

Frequently asked questions

Promontory Therapeutics is located in Manhattan, New York, US.

You can reach Promontory Therapeutics at +16463802441.

Promontory Therapeutics generates an estimated annual revenue of $1,283,325. This revenue figure reflects the company's market position and business performance in its industry.

Promontory Therapeutics has an estimated valuation of $4,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Promontory Therapeutics was founded in 2010, making it 16 years old. The company has established itself as a significant player in its industry over this time.

Promontory Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.